Login to Your Account

Perosphere lands fast track status for its anticoagulant reversal agent PER977

By Michael Fitzhugh
Staff Writer

Thursday, April 2, 2015
Perosphere Inc., a private company focused on bringing a broadly applicable anticoagulant reversal agent to market, has won FDA fast track status for the synthetic small molecule ahead of planned phase III studies.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription